Median WTP estimates and average uptake rates compared with traditional finger prick
| The Netherlands WTP | Poland WTP | |||
| Median | IQR | Median | IQR | |
| Increase precision from | ||||
| Low to medium | 15.94 | 27.73–3.93 | 10.18 | −3.19 to 21.23*** |
| Medium to high | 15.87 | 3.72–26.43 | 22.17 | 4.54–41.84 |
| Low to high | 31.82 | 7.60–54.73 | 33.64 | 1.02–59.45 |
| Reduce daily finger-pricks: 2–0 | 32.71 | 14.34–63.41 | 13.35 | 4.28–30.34*** |
| Improve chance of skin irritation | ||||
| High to medium | 10.39 | 18.86–5.56 | 13.8 | 6.38–27.87** |
| Medium to low | 18.7 | 12.52–32.79 | 16.06 | 8.20–34.52* |
| High to low | 28.97 | 16.55–52.5 | 29.83 | 14.47–61.74 |
| Improve effort from medium to low | 11.32 | 8.78–22.24 | 3.55 | 2.31–7.4*** |
| Improve glucose information with | ||||
| An arrow showing blood glucose is changing | 10.22 | 7.70–19.49 | 2.58 | 1.68–5.38*** |
| Daily trend information | 14.19 | 7.92–20.07 | 4.6 | 2.99–9.59*** |
| Get a glucose alarm | 14.19 | 7.15–25.74 | 12.67 | 7.44–24.02 |
| WTP to not use finger-prick test | 27.74 | −231.85 to 278.23 | 65.01 | −183.76 to 295.5** |
| Estimated Uptake Rates | Most preferred device (%)† | FGM proxy device (%)‡ | FGM proxy with reduced cost (%)§ | |
| Total samples | ||||
| The Netherlands (n=226) | 63.6 | 44.4 | 54.8 | |
| Poland (n=261) | 77.1*** | 56.1** | 67.6*** | |
| Age 18–50 | ||||
| Netherlands (n=88) | 69.1 | 51.7 | 59.9 | |
| Poland (n=202) | 78.9* | 59.5*** | 69.5* | |
| Age 50 and over | ||||
| Netherlands (n=137) | 60.4 | 39.9 | 51.9 | |
| Poland (n=59) | 70.9 | 44.3 | 61.1 | |
| FP only users | ||||
| Netherlands (n=128) | 57.5 | 37.8 | 48 | |
| Poland (n=211) | 75*** | 53.6*** | 65.8*** | |
| CGM/FGM users | ||||
| Netherlands (n=38) | 78.2 | 66.7 | 73 | |
| Poland (n=39) | 85.3 | 70.2 | 76.7 | |
| Type 1 | ||||
| Netherlands (n=65) | 70.8 | 53.1 | 62 | |
| Poland (n=83) | 81.7 | 63.2 | 71.7 | |
| Type 2 | ||||
| Netherlands (n=157) | 61 | 41 | 52.3 | |
| Poland (n=167) | 74.8** | 52.8** | 65.6** | |
Note for WTP estimates: estimates are only presented for attribute improvement where level increases were found to be significant in the mixed logit model; costs presented in euros; Mood’s test of equality of median values was used to assess difference between countries.
Significant differences between countries: *p<0.05, **p<0.01, ***p<0.001.
†High precision, 0 finger pricks, low effort, low chance of skin irritation, €25 /month, glucose information with trendline, alarm.
‡Moderate precision, 0 finger pricks, moderate effort, moderate chance of skin irritation, €100/month, arrow information, no alarm.
§Moderate precision, 0 finger pricks, moderate effort, moderate chance of skin irritation, €25/month, arrow information, no alarm.
CGM, continuous glucose monitor; FGM, flash glucose monitor; WTP, willingness to pay.